Treatment of gastrointestinal disease with ppar modulators
Methods and compositions are provided for treating a host having a gastrointestinal (GI) disease by administering to the host a composition containing a pharmaceutically effective amount of a modulator of a Peroxisome Proliferator Activated Receptor (PPAR), particularly a modulator of PPAR gamma . Screening methods are also provided for identifying PPAR modulators which utilize cells derived from gastrointestinal tissue which express PPARs
21916159
Applicant(s): Ligand Pharm Inc [Us], Pasteur Institut [Fr], Lefebvre Anne-Marie, Auwerx Johan, Briggs Michael R
Alternative title(s) : (fr) Traitement de troubles gastro-intestinaux au moyen de modulateurs du recepteur active de la proliferation des peroxysomes (ppar)
Patent number | Country code | Kind code | Date issued |
AU6773598 | AU | A | 1998-10-20 |
WO9843081 | WO | A1 | 1998-10-01 |